EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tumor Microenvironment Drives the Cross-Talk Between Co-Stimulatory and Inhibitory Molecules in Tumor-Infiltrating Lymphocytes: Implications for Optimizing Immunotherapy Outcomes

Ornella Franzese

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312848 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ornella Franzese. Beteiligte Einrichtung: Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy. Hauptthemen laut MEDLINE: Tumor Microenvironment, Lymphocytes, Tumor-Infiltrating, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Rome "Tor Vergata", “Frailcures” (University of Rome Tor Vergata, to O.F.).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review explores some of the complex mechanisms underlying antitumor T-cell response, with a specific focus on the balance and cross-talk between selected co-stimulatory and inhibitory pathways. The tumor microenvironment (TME) fosters both T-cell activation and exhaustion, a dual role influenced by the local presence of inhibitory immune checkpoints (ICs), which are exploited by cancer cells to evade immune surveillance. Recent advancements in IC blockade (ICB) therapies have transformed cancer treatment. However, only a fraction of patients respond favorably, highlighting the need for predictive biomarkers and combination therapies to overcome ICB resistance. A crucial aspect is represented by the complexity of the TME, which encompasses diverse cell types that either enhance or suppress immune responses. This review underscores the importance of identifying the most critical cross-talk between inhibitory and co-stimulatory molecules for developing approaches tailored to patient-specific molecular and immune profiles to maximize the therapeutic efficacy of IC inhibitors and enhance clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentLymphocytes, Tumor-InfiltratingImmunotherapyNeoplasmsImmune Checkpoint InhibitorsHumansAnimals

Stichwörter der Autor:innen

T cellsT-cell activationaxisco-stimulatory moleculescross-talkimmune checkpointimmune checkpoint blockadeinhibitory moleculestumor micro-environment

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Förderung

  • University of Rome "Tor Vergata"
  • “Frailcures” (University of Rome Tor Vergata, to O.F.)

Zitieren

APA

Franzese, O. (2024). Tumor Microenvironment Drives the Cross-Talk Between Co-Stimulatory and Inhibitory Molecules in Tumor-Infiltrating Lymphocytes: Implications for Optimizing Immunotherapy Outcomes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312848

Vancouver

Franzese O. Tumor Microenvironment Drives the Cross-Talk Between Co-Stimulatory and Inhibitory Molecules in Tumor-Infiltrating Lymphocytes: Implications for Optimizing Immunotherapy Outcomes. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312848

BibTeX
@article{Franzese2024,
  author = {Franzese, Ornella},
  title = {Tumor Microenvironment Drives the Cross-Talk Between Co-Stimulatory and Inhibitory Molecules in Tumor-Infiltrating Lymphocytes: Implications for Optimizing Immunotherapy Outcomes},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312848}
}
Kostenlos starten →